XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Paid-In Capital
Retained Earnings
Unearned ESOP Shares
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Jun. 30, 2023   65,864,000        
Balance at beginning of period at Jun. 30, 2023 $ 869,284 $ 659 $ 503,332 $ 457,611 $ (22,862) $ (69,456)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income (Loss) (3,985)     (3,985)    
Other comprehensive loss, net of income tax 5,626         5,626
ESOP shares committed to be released 771   (202)   973  
Stock repurchases (in shares)   (1,505,000)        
Stock repurchases (11,240) $ (15) (11,225)      
Issuance of stock under stock benefit plans (in shares)   133,000        
Issuance of stock under stock benefit plan 0 $ 1 (1)      
Stock-based compensation expense 1,792   1,792      
Cancellation of shares issued for restricted stock awards (in shares)   (47,000)        
Cancellation of shares issued for restricted stock awards (399)   (399)      
Cash dividends declared (13,871)     (13,871)    
Balance at end of period (in shares) at Dec. 31, 2023   64,445,000        
Balance at end of period at Dec. 31, 2023 847,978 $ 645 493,297 439,755 (21,889) (63,830)
Balance at beginning of period (in shares) at Sep. 30, 2023   65,132,000        
Balance at beginning of period at Sep. 30, 2023 849,534 $ 652 497,269 460,464 (22,375) (86,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income (Loss) (13,827)     (13,827)    
Other comprehensive loss, net of income tax 22,646         22,646
ESOP shares committed to be released 391   (95)   486  
Stock repurchases (in shares)   (687,000)        
Stock repurchases (4,773) $ (7) (4,766)      
Stock-based compensation expense 889   889      
Cash dividends declared (6,882)     (6,882)    
Balance at end of period (in shares) at Dec. 31, 2023   64,445,000        
Balance at end of period at Dec. 31, 2023 $ 847,978 $ 645 493,297 439,755 (21,889) (63,830)
Balance at beginning of period (in shares) at Jun. 30, 2024 64,434,424 64,434,000        
Balance at beginning of period at Jun. 30, 2024 $ 753,571 $ 644 493,680 343,326 (20,916) (63,163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income (Loss) 12,658     12,658    
Other comprehensive loss, net of income tax (8,934)         (8,934)
ESOP shares committed to be released 709   (264)   973  
Issuance of stock under stock benefit plans (in shares)   207,000        
Issuance of stock under stock benefit plan 0 $ 2 (2)      
Stock-based compensation expense 1,027   1,027      
Cancellation of shares issued for restricted stock awards (in shares)   (61,000)        
Cancellation of shares issued for restricted stock awards (349)   (349)      
Cash dividends declared $ (13,829)     (13,829)    
Balance at end of period (in shares) at Dec. 31, 2024 64,579,683 64,580,000        
Balance at end of period at Dec. 31, 2024 $ 744,853 $ 646 494,092 342,155 (19,943) (72,097)
Balance at beginning of period (in shares) at Sep. 30, 2024   64,580,000        
Balance at beginning of period at Sep. 30, 2024 751,537 $ 646 493,523 342,522 (20,430) (64,724)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income (Loss) 6,566     6,566    
Other comprehensive loss, net of income tax (7,373)         (7,373)
ESOP shares committed to be released 379   (108)   487  
Stock-based compensation expense 677   677      
Cash dividends declared $ (6,933)     (6,933)    
Balance at end of period (in shares) at Dec. 31, 2024 64,579,683 64,580,000        
Balance at end of period at Dec. 31, 2024 $ 744,853 $ 646 $ 494,092 $ 342,155 $ (19,943) $ (72,097)